Dr. Rajkumar from the Mayo Clinic explains why many have been disappointed by the ODAC decision to recommend not approving Benrep for relapsed/refractory multiple myeloma. Thought provoking. This was taped live while we broadcasted on Twitter Spaces on 7/22/2025.
